Neutrophil and platelet increases with luspatercept in lower-risk MDS: secondary endpoints from the MEDALIST trial.

ABSTRACT:

SUBMITTER: Garcia-Manero G 

PROVIDER: S-EPMC8796653 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature